ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells

Cancer Letters

Volumn 330, Issue 1, 2013, Pages 67-73

  Xiao, Chuan Xing ^a   Yang, Xiao Ning ^a   Huang, Qing Wen ^a   Zhang, Yu Qin ^a,b,c   Lin, Bi Yun ^a   Liu, Jing Jing ^a   Liu, Yun Peng ^a   Jazag, Amarsanaa ^c   Guleng, Bayasi ^a,b   Ren, Jian Lin ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c National Institute of Medical Research   (Mongolia)

Author keywords

ECHS1; HBs binding protein; HepG2 cell apoptosis

Indexed keywords

BIM PROTEIN; BINDING PROTEIN; ECHS1 PROTEIN; HEPATITIS B SURFACE ANTIGEN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTEIN MCL 1; PUMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; ENOYL-COA HYDRATASE; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MITOCHONDRIA; PHOSPHORYLATION; PROTEIN BINDING; TRANSFECTION;

HEPATITIS B VIRUS;

EID: 84872840780     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.11.030     Document Type: Article

References (36)

1. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infectious Diseases 2002, 2:395-403.
2. Hildt E., Hofschneider P.H., Urban S. The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Seminars in Virology 1996, 7:333-347.
3. Schuster R., Gerlich W.H., Schaefer S. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 2000, 19:1173-1180.
4. Tan T.L., Feng Z.Q., Lu Y.W., Chan V., Chen W.N. Adhesion contact kinetics of HepG2 cells during hepatitis B virus replication: Involvement of SH3-binding motif in HBX. Biochimica Et Biophysica Acta-Molecular Basis of Disease 2006, 1762:755-766.
5. Li L., Chen S.H., Yu C.H., Li Y.M., Wang S.Q. Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray. Journal of Proteome Research 2008, 7:611-620.
6. Liver E.A.S. EASL clinical practice guidelines: management of chronic hepatitis B. Journal of Hepatology 2009, 50:227-242.
7. Lok A.S.F., McMahon B.J. Chronic hepatitis B: update. Hepatology 2009, 50(2009):661-662.
8. Zhao C., Fang C.Y., Tian X.C., Wang L., Yang P.Y., Wen Y.M. Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. Journal of Medical Virology 2007, 79:1478-1484.
9. Kim W., Lim S.O., Kim J.S., Ryu Y.H., Byeon J.Y., Kim H.J., Kim Y.I., Heo J.S., Park Y.M., Jung G.H. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clinical Cancer Research 2003, 9:5493-5500.
10. Pan J.S., Zhou F., Xie C.X., Cai J.Y., Chen J.M., Zhang Z.P., Dong J., Xu H.Z., Shi H.X., Ren J.L. Aldolase A-HBsAg interaction and its effect on ultraviolet radiation induced apoptosis in 293FT cells. Journal of Gastroenterology and Hepatology 2010, 25:1702-1709.
11. Zhou F.L., Ren J., Lu Y.P., Chen M.Y. Screening of hepatocyte proteins binding to whole S protein of hepatitis B virus by yeast two-hybrid system. Zhonghua Gan Zang Bing Za Zhi 2008, 16:304-305.
12. Fong J.C., Schulz H. Purification and properties of pig heart crotonase and the presence of short chain and long chain enoyl coenzyme A hydratases in pig and guinea pig tissues. Journal of Biological Chemistry 1977, 252:542-547.
13. Bendayan M., Reddy M.K., Hashimoto T., Reddy J.K. Immunocytochemical localization of fatty acid metabolizing heat-stable and heat-labile enoyl-coenzyme A (CoA) hydratases in liver and renal cortex. Journal of Histochemistry and Cytochemistry 1983, 31:509-516.
14. Balabanov S., Zimmermann U., Protzel C., Scharf C., Klebingat K.J., Walther R. Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. European Journal of Biochemistry 2001, 268:5977-5980.
15. Fratelli M., Demol H., Puype M., Casagrande S., Villa P., Eberini I., Vandekerckhove J., Gianazza E., Ghezzi P. Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells. Proteomics 2003, 3:1154-1161.
16. Sakata M., Kurachi H., Morishige K., Ogura K., Yamaguchi M., Nishio Y., Ikegami H., Miyake A., Murata Y. Messenger RNA differential display reverse-transcriptase polymerase chain reaction analysis of a progestogen-suppressive gene in a human endometrial-cancer cell line. International Journal of Cancer 1998, 78:125-129.
17. Zhang X.Q., Yang J.T., Guo Y.B., Ye H., Yu C.H., Xu C.F., Xu L., Wu S.F., Sun W., Wei H.D., Gao X., Zhu Y.P., Qian X.H., Jiang Y., Li Y.M., He F.C. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme A hydratase down-regulation exacerbates hepatic steatosis. Hepatology 2010, 51:1190-1199.
18. Hale D.E., Bennett M.J. Fatty acid oxidation disorders: a new class of metabolic diseases. Journal of Pediatrics 1992, 121:1-11.
19. Coates P.M., Tanaka K. Molecular basis of mitochondrial fatty acid oxidation defects. Journal of Lipid Research 1992, 33:1099-1110.
20. Yano M., Terada K., Mori M. AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. Journal of Cell Biology 2003, 163:45-56.
21. Takahashi M., Watari E., Shinya E., Shimizu T., Takahashi H. Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells. Antiviral Research 2007, 75:152-158.
22. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnology 2002, 20:497-500.
23. Jazag A., Ijichi H., Kanai F., Imamura T., Guleng B., Ohta M., Imamura J., Tanaka Y., Tateishi K., Ikenoue T., Kawakami T., Arakawa Y., Miyagishi M., Taira K., Kawabe T., Omata M. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene 2005, 24:662-671.
24. Guleng B., Tateishi K., Ohta M., Kanai F., Jazag A., Ijichi F., Tanaka Y., Washida M., Morikane K., Fukushima Y., Yamori T., Tsuruo T., Kawabe T., Miyagishi M., Taira K., Sata M., Omata M. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Research 2005, 65:5864-5871.
25. Hildt E., Hofschneider P.H. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Research 1998, 154:315-329.
26. Hildt E., Munz B., Saher G., Reifenberg K., Hofschneider P.H. The PreS2 activator MJBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO Journal 2002, 21:525-535.
27. Liang X.H., Liu Y.G., Zhang Q., Gao L.F., Han L.H., Ma C.H., Zhang L.N., Chen Y.H.H., Sun W.S. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. Journal of Immunology 2007, 178:503-510.
28. Liang X.H., Sun W.S., Gao L.F., Ma C.H., Han L.H., Chen Y.H. Hepatitis B virus X protein modulates the apoptosis of hepatoma cell line induced by TRAIL. Science in China Series C-Life Sciences 2005, 48:277-286.
29. Foo N.C., Ahn B.Y., Ma X.H., Hyun W., Yen T.S.B. Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology 2002, 36:1400-1407.
30. Arzberger S., Hosel M., Protzer U. Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus. Journal of Virology 2010, 84:11994-12001.
31. Yokoyama Y., Kuramitsu Y., Takashima M., Iizuka N., Toda T., Terai S., Sakaida I., Oka M., Nakamura K., Okita K. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4:2111-2116.
32. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes & Development 1999, 13:1899-1911.
33. Raisova M., Hossini A.M., Eberle J., Riebeling C., Wieder T., Sturm I., Daniel P.T., Orfanos C.E., Geilen C.C. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. Journal of Investigative Dermatology 2001, 117:333-340.
34. Lechel A., Holstege H., Begus Y., Schienke A., Kamino K., Lehmann U., Kubicka S., Schirmacher P., Jonkers J., Rudolph K.L. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease. Gastroenterology 2007, 132:1465-1475.
35. Tsuruta F., Masuyama N., Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. Journal of Biological Chemistry 2002, 277:14040-14047.
36. Yamaguchi H., Wang H.G. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001, 20:7779-7786.